Patrick Oeckl is a research group leader at the German Center for Neurodegenerative Diseases (DZNE) and at the Ulm University Hospital, Department of Neurology and works on the discovery and validation of fluid biomarkers for neurodegenerative diseases. His group uses mass spectrometry-based proteomics (targeted/shotgun) and immunoassays for biomarker research in blood and CSF with many years of experience from industry and academia.